United States · 
What does Gilmartin Capital invest in?
Gilmartin Capital invests most often at Series C and Series D (100% of the rounds on record), in sectors such as Diagnostics, Ivd and Bioimaging.
Gilmartin Capital highlights
- 01
2 rounds on record
- 02
Mostly Series C and Series D: 100% of its rounds
What they do
We invest in entrepreneurs targeting platforms that influence large or underserved diseases, technologies that accelerate and expand scientific discovery, and solutions that impact the cost, site and delivery of care.From their own website
- Type
- Private equity (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries BGrowth
- Sectors
- DiagnosticsIvdBioimaging
- Based in
- California, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first2 appearances
- 2025
2 rounds
- Sept
- Aug
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration1 named
DRDavid Ryan LewisManager of Gilmartin Capital GP I LLC, the General PartneriFiling they signed
We also hold 1 person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$61Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- Gilmartin Capital LLC
- SEC number
- CRD 317560